DE2937698A1
(de)
*
|
1979-09-18 |
1981-04-02 |
A. Nattermann & Cie GmbH, 5000 Köln |
N-propionylsarcosinanilide, deren herstellungsverfahren und arzneimittel auf deren basis
|
DK373383A
(da)
*
|
1982-08-20 |
1984-02-21 |
Midit |
Fremgangsmaade til fremstilling af omega-aminosyrederivater
|
US4798687A
(en)
*
|
1987-02-06 |
1989-01-17 |
Pennwalt Corporation |
2-Amino-N-[1,2-Diphenyl-1-(thifluoromethyl)ethyl]acetamide derivatives
|
US4904681A
(en)
*
|
1987-12-01 |
1990-02-27 |
G. D. Searle & Co. |
D-cycloserine and its prodrugs as cognitive enhancers
|
US4891058A
(en)
*
|
1988-07-18 |
1990-01-02 |
Ici Americas Inc. |
1-alkyl-3-aryl imidazolidine-2,4-diones and herbicidal use
|
US5278191A
(en)
*
|
1988-08-31 |
1994-01-11 |
G. D. Searle & Co. |
Diphenylmethylaminoacetamide derivatives as anti-convulsants
|
US5288905A
(en)
*
|
1988-10-07 |
1994-02-22 |
G. D. Searle & Co. |
Glycyl urea derivatives as anti-convulsants
|
US4944796A
(en)
*
|
1988-11-14 |
1990-07-31 |
Ici Americas Inc. |
Certain 2-(disubstituted amino) acetanilide herbicides
|
DE3915755A1
(de)
*
|
1989-05-13 |
1990-11-29 |
Bayer Ag |
Fungizide mittel sowie substituierte aminosaeureamid-derivate und deren herstellung
|
IL94466A
(en)
*
|
1989-05-25 |
1995-01-24 |
Erba Carlo Spa |
Pharmaceutical preparations containing the history of A-amino carboxamide N-phenylalkyl are converted into such new compounds and their preparation
|
US5075337A
(en)
*
|
1989-07-26 |
1991-12-24 |
G. D. Searle & Co. |
Alpha-deuterated 2-alkylaminoacetamide derivatives having reduced toxicity for treatment of CNS disorders
|
US5153226A
(en)
*
|
1989-08-31 |
1992-10-06 |
Warner-Lambert Company |
Acat inhibitors for treating hypocholesterolemia
|
DE4102042A1
(de)
*
|
1991-01-24 |
1992-07-30 |
Bayer Ag |
Substituierte aminosaeureamid-derivate deren herstellung und verwendung als fungizide
|
US5141960A
(en)
*
|
1991-06-25 |
1992-08-25 |
G. D. Searle & Co. |
Tricyclic glycinamide derivatives as anti-convulsants
|
GB9306899D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylalkylaminobenzyl) aminopropionamide derivatives and process for their preparation
|
GB9306886D0
(en)
*
|
1993-04-01 |
1993-05-26 |
Erba Carlo Spa |
Substituted (arylakoxybenzyl) aminopropanamide derivatives and process for their preparation
|
US5585358A
(en)
*
|
1993-07-06 |
1996-12-17 |
Yissum Research Development Corporation Of The Hebrew University Of Jerusalem |
Derivatives of valproic acid amides and 2-valproenoic acid amides, method of making and use thereof as anticonvulsant agents
|
US6191165B1
(en)
*
|
1996-05-31 |
2001-02-20 |
Allelix Neuroscience Inc. |
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
EP1014966B1
(en)
*
|
1996-05-31 |
2006-08-02 |
Allelix Neuroscience Inc. |
Pharmaceutical for treatment of neurological and neuropsychiatric disorders
|
IT1283489B1
(it)
*
|
1996-07-23 |
1998-04-21 |
Chiesi Farma Spa |
Ammidi di alfa-amminoacidi,loro preparazione e loro impiego terapeutico
|
GB9727523D0
(en)
|
1997-12-31 |
1998-02-25 |
Pharmacia & Upjohn Spa |
Alpha-aminoamide derivatives useful as analgesic agents
|
ATE375975T1
(de)
*
|
1998-03-26 |
2007-11-15 |
Univ Saskatchewan |
Aliphatische aminosäure und aminophosphonsäure, aminonitrile und aminotetrazole als zellulares rettungsmittel
|
US6984754B1
(en)
|
1998-03-26 |
2006-01-10 |
University Of Saskatchewan Technologies Inc. |
Aliphatic amino carboxylic and amino phosphonic acids amino nitriles and amino tetrazoles as cellular rescue agents
|
AU2985100A
(en)
*
|
1999-02-08 |
2000-08-25 |
Checkpoint Genetics, Inc. |
(n)-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
|
HUP0600526A2
(en)
*
|
2000-07-21 |
2006-11-28 |
Teva Pharma |
Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder
|
ATE301995T1
(de)
*
|
2000-08-17 |
2005-09-15 |
Teva Pharma |
Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
|
ATE397584T1
(de)
*
|
2000-11-21 |
2008-06-15 |
Ucb Pharma Sa |
N-alkylierte gaba verbindungen, verfahren zu deren herstellung und deren verwendung als arzneimittel
|
SK287304B6
(sk)
|
2001-02-16 |
2010-06-07 |
Nps Pharmaceuticals, Inc. |
Substituované amínové deriváty ako inhibítory GlyT-1, farmaceutické prostriedky s ich obsahom, ich použitie, spôsob ich prípravy, ich medziprodukty a spôsob ich prípravy
|
US20030035784A1
(en)
*
|
2001-03-05 |
2003-02-20 |
Kao Corporation |
Hair cosmetic, aminocarboxylic acid amide and method for producing the same
|
NZ531586A
(en)
|
2001-09-03 |
2005-09-30 |
Newron Pharm Spa |
Pharmaceutical composition comprising gabapentin or an analogue thereof and an alpha-aminoamide and its analgesic use
|
EP1438956A1
(en)
*
|
2003-01-16 |
2004-07-21 |
Newron Pharmaceuticals S.p.A. |
Alpha-aminoamide derivatives useful as antimigraine agents
|
KR101277520B1
(ko)
*
|
2004-09-10 |
2013-06-21 |
뉴론 파마슈티칼즈 에스. 피. 에이. |
(할로벤질옥시)벤질아미노-프로판아미드를 포함하는 선택적 나트륨 및/또는 칼슘 채널 조절제로서 유용한 약제학적 조성물
|
CA2577321C
(en)
*
|
2004-09-13 |
2013-07-23 |
Jeffrey A. Levine |
Alkylaminoacetamide lubricant additives
|
FR2896991A1
(fr)
*
|
2006-02-03 |
2007-08-10 |
Inst Nat Sante Rech Med |
Procede pour preparer un compose organique a l'etat solide et compositions pharmaceutiques comprenant ledit compose organique
|
CN102351733B
(zh)
*
|
2011-07-21 |
2014-03-19 |
凯莱英医药化学(阜新)技术有限公司 |
一种制备2-氨基-n,n-二甲基乙酰胺盐酸盐的方法
|
CN106795096B
(zh)
|
2014-06-25 |
2020-05-29 |
爱康泰生治疗公司 |
用于递送核酸的新型脂质和脂质纳米颗粒制剂
|
JP6053724B2
(ja)
*
|
2014-06-26 |
2016-12-27 |
国立大学法人九州大学 |
イオン交換樹脂及び金属の吸着分離方法
|
JP7072386B2
(ja)
|
2015-06-29 |
2022-05-20 |
アクイタス セラピューティクス インコーポレイテッド |
核酸の送達のための脂質および脂質ナノ粒子製剤
|
RS63986B1
(sr)
|
2015-10-28 |
2023-03-31 |
Acuitas Therapeutics Inc |
Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
|
CN106187829B
(zh)
*
|
2016-07-29 |
2017-12-15 |
万华化学集团股份有限公司 |
一种制备乙二胺基乙磺酸盐的方法
|
US11357856B2
(en)
|
2017-04-13 |
2022-06-14 |
Acuitas Therapeutics, Inc. |
Lipids for delivery of active agents
|
WO2018200943A1
(en)
|
2017-04-28 |
2018-11-01 |
Acuitas Therapeutics, Inc. |
Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
|
WO2019036008A1
(en)
|
2017-08-16 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
|
CA3073018A1
(en)
*
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
US11542225B2
(en)
|
2017-08-17 |
2023-01-03 |
Acuitas Therapeutics, Inc. |
Lipids for use in lipid nanoparticle formulations
|
WO2019036030A1
(en)
|
2017-08-17 |
2019-02-21 |
Acuitas Therapeutics, Inc. |
LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
|
KR101953366B1
(ko)
|
2018-12-26 |
2019-02-28 |
정종문 |
침향을 포함하는 기억력 및 인지능력을 향상시키는 기능성 건강식품 및 이의 제조방법
|
BR112021013654A2
(pt)
|
2019-01-11 |
2021-09-14 |
Acuitas Therapeutics, Inc. |
Lipídeos para liberação de nanopartículas lipídicas de agentes ativos
|
USD926577S1
(en)
|
2019-09-23 |
2021-08-03 |
Verdant Ventures |
Tamper-resistant lid assembly
|
US11326923B2
(en)
|
2019-10-08 |
2022-05-10 |
Verdant Ventures |
Tamper-resistant lid assembly for dispensing a premeasured amount of liquid
|
IL299787A
(en)
|
2020-07-16 |
2023-03-01 |
Acuitas Therapeutics Inc |
Cationic lipids for use in lipid nanoparticles
|